Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo
Journal Article
Overview
publication date
- December 1, 2017
has subject area
- Adult
- Benzazepines
- Benzazepines - Varenicline
- Environment and Public Health - Double-Blind Method
- Environment and Public Health - Placebo Effect
- Female
- Health Care Evaluation Mechanisms - Double-Blind Method
- Health Care Evaluation Mechanisms - Treatment Outcome
- Health Care Quality, Access, and Evaluation - Placebo Effect
- Health Services Administration - Treatment Outcome
- Humans
- Investigative Techniques - Double-Blind Method
- Male
- Methods - Double-Blind Method
- Middle Aged
- Molecular Mechanisms of Pharmacological Action - Nicotinic Agonists
- Physiological Effects of Drugs - Nicotinic Agonists
- Prognosis - Treatment Outcome
- Quinoxalines - Varenicline
- Smoking
- Smoking - Tobacco Smoking
- Smoking Cessation
- Tobacco Use - Tobacco Smoking
has restriction
- closed
Date in CU Experts
- September 16, 2017 9:13 AM
Full Author List
- Littlewood RA; Claus ED; Wilcox CE; Mickey J; Arenella PB; Bryan AD; Hutchison KE
author count
- 7
citation count
- 8
published in
- Psychopharmacology Journal
Other Profiles
International Standard Serial Number (ISSN)
- 0033-3158
Electronic International Standard Serial Number (EISSN)
- 1432-2072
Digital Object Identifier (DOI)
Additional Document Info
start page
- 3417
end page
- 3429
volume
- 234
issue
- 23-24